Clinical characteristics, treatment, and prognosis of 74 2019 novel coronavirus disease patients in Hefei: A single-center retrospective study | Canada Hyperbarics Skip to main content
Retrospective Study Medicine (Baltimore) 2021

Clinical characteristics, treatment, and prognosis of 74 2019 novel coronavirus disease patients in Hefei: A single-center retrospective study

Yang J, Wu K, Ding A, Li L, Lu H, Zhu W, et al. — Medicine (Baltimore), 2021

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers in China conducted a retrospective study to describe the epidemiology, clinical characteristics, treatment, and prognosis of 74 hospitalized COVID-19 patients.

What They Found

The median incubation period and the median time from symptom onset to hospital admission were both 6 days, with a median length of hospitalization of 13 days. Fever was the most common symptom, affecting 83.78% of patients, followed by cough in 74.32%. Notably, 50.00% of intensive care unit (ICU) patients had a T helper cell to cytotoxic T cell ratio (CD4/CD8) lower than 1.1.

What This Means for Canadian Patients

This study offers insights into the early clinical features and progression of COVID-19 in a specific region during the initial phase of the pandemic. While not an HBOT study, understanding the characteristics of infectious diseases like COVID-19 contributes to general medical knowledge and public health preparedness.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a single-center retrospective study, which may limit the generalizability of its findings to broader populations.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category COVID-19 / Long COVID
Source Pubmed
PubMed ID 34032692
Year Published 2021
Journal Medicine (Baltimore)
MeSH Terms Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antiviral Agents; Blood Sedimentation; C-Reactive Protein; COVID-19; COVID-19 Nucleic Acid Testing; Child; Child, Preschool; China; Cities; Cough; Female; Fever; Follow-Up Studies; Geography; Humans; Hyperbaric Oxygenation; Length of Stay; Lung; Male; Middle Aged; RNA, Viral; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed; Young Adult

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.